Id: | acc4512 |
Group: | 1sens |
Protein: | AMPK |
Gene Symbol: | Prkaa2 |
Protein Id: | Q8BRK8 |
Protein Name: | AAPK2_MOUSE |
PTM: | phosphorylation |
Site: | Thr172 |
Site Sequence: | MMSDGEFLRTSCGSPNYAAPE |
Disease Category: | Endocrine and metabolic diseases |
Disease: | Diabetes Mellitus |
Disease Subtype: | Diabetic Tubulopathy |
Disease Cellline: | |
Disease Info: | |
Drug: | Chloroquine + amodiaquine |
Drug Info: | Chloroquine is an antimalarial drug used to prevent and treat malaria | Amodiaquine is also an antimalarial medicine often used for the treatment of malaria. |
Effect: | modulate |
Effect Info: | Chloroquine and amodiaquine enhanced the phosphorylation level of AMPK in diabetic renal tubular lesions. |
Note: | drug comb |
Score: | 4.0 |
Pubmed(PMID): | 29884802 |
Sentence Index: | 29884802_0 |
Sentence: | Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy. |
Sequence & Structure:
MAEKQKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPDYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERMPPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKACDIMAEVYRAMKQLGFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLVDSRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRARSSFDSSTAENHSLSGSLTGSLTGSTLSSASPRLGSHTMDFFEMCASLITALAR
No data.
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
T | 172 | U | Cardiomyopathy | Phosphorylation | 37733758 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.